EUVIMEDEUVIMED entdecken
Crossref

Synthesis, Conformational Analysis, Antioxidant and Enzyme Inhibition Activity, Molecular Docking, and DFT Studies of New Chiral Hydrazide–Hydrazone Derivatives

Şenel Teke Tunçel iD, Yusuf Sıcak iD, M Oluş Özbek iD, Abdullahi Ibrahim Uba iD, Ayşegül Karaküçük-İyidoğan iD, Emine Elçin Oruç-Emre iD

Chirality · 2025

DOI: 10.1002/chir.70041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chirality, 2025. Verfasst von Şenel Teke Tunçel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, İstanbul Arel University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Hydrazones, Molecular Docking Simulation, Antioxidants, Enzyme Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Gaziantep Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new series of chiral hydrazide‐hydrazone derivatives were synthesized and evaluated their acetylcholinesterase (AChE), butyrylcholinesterase (BChE), tyrosinase and urease inhibition and antioxidant activities. The chemical structures of newly synthesized chiral aryl hydrazide‐hydrazone derivatives were clarified using UV–Vis, IR, 1 H and 13 C NMR, and mass spectroscopies. According to NMR data, due to the partial double bond character of the amide C‐N bond, two conformational isomers ( E and Z ) exist in solution. Based on this information, the conformational properties of the synthesized compounds were investigated using temperature‐dependent NMR spectroscopy and DFT. The results of DFT studies revealed that E (C=N) ‐ E (C(O)‐N) conformer is the most stable structure for the synthesized hydrazones. In addition, the enzyme inhibition potentials of the synthesized compounds were evaluated. Among all chiral hydrazide‐hydrazones, compound 3b (containing nitro group in the hydrazone part) had the best inhibition profile against AChE, whereas compound 3d was found to be the most active compound against BChE. In addition, compound 3d , which carries a methoxy group in both the benzamide and the hydrazone moiety, attracted attention due to its good activity against all examined enzymes. Furthermore, molecular docking calculations were performed to get insights into the interaction patterns between the synthesized compounds and the selected target protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrazonesMolecular Docking SimulationAntioxidantsEnzyme InhibitorsHydrazinesButyrylcholinesteraseAcetylcholinesteraseStereoisomerismDensity Functional TheoryUreaseMonophenol MonooxygenaseMolecular ConformationCholinesterase Inhibitors

Stichwörter der Autor:innen

DFTanticholinesterase activityconformational analysishydrazide–hydrazonemolecular dockingrotational barrier

Substanzen

HydrazonesAntioxidantsButyrylcholinesteraseAcetylcholinesteraseEnzyme InhibitorsUreaseMonophenol MonooxygenaseHydrazinesCholinesterase Inhibitors

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, İstanbul Arel University, Istanbul, Turkey.
  • Department of Medicinal and Aromatic Plants, Köyceğiz Vocational School, Muğla Sıtkı Koçman University, Muğla, Turkey.
  • Department of Chemical Engineering, Gebze Technical University, Kocaeli, Turkey.
  • Department of Chemistry, Gaziantep University, Gaziantep, Turkey.

ORCID-Profile: Şenel Teke Tunçel, Yusuf Sıcak, M Oluş Özbek, Abdullahi Ibrahim Uba, Ayşegül Karaküçük-İyidoğan, Emine Elçin Oruç-Emre

Förderung

  • Gaziantep Üniversitesi

Zitieren

APA

Teke Tunçel, Ş., Sıcak, Y., Özbek, M. O., Uba, A. I., Karaküçük-İyidoğan, A., & Oruç-Emre, E. E. (2025). Synthesis, Conformational Analysis, Antioxidant and Enzyme Inhibition Activity, Molecular Docking, and DFT Studies of New Chiral Hydrazide–Hydrazone Derivatives. Chirality. https://doi.org/10.1002/chir.70041

Vancouver

Teke Tunçel Ş, Sıcak Y, Özbek MO, Uba AI, Karaküçük-İyidoğan A, Oruç-Emre EE. Synthesis, Conformational Analysis, Antioxidant and Enzyme Inhibition Activity, Molecular Docking, and DFT Studies of New Chiral Hydrazide–Hydrazone Derivatives. Chirality. 2025. doi:10.1002/chir.70041

BibTeX
@article{TekeTunel2025,
  author = {Teke Tunçel, Şenel and Sıcak, Yusuf and Özbek, M Oluş and Uba, Abdullahi Ibrahim and Karaküçük-İyidoğan, Ayşegül and Oruç-Emre, Emine Elçin},
  title = {Synthesis, Conformational Analysis, Antioxidant and Enzyme Inhibition Activity, Molecular Docking, and DFT Studies of New Chiral Hydrazide–Hydrazone Derivatives},
  journal = {Chirality},
  year = {2025},
  doi = {10.1002/chir.70041}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche